Andrew Hykes - Feb 18, 2023 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
President and CEO, Director
Signature
/s/ Angela Ahmad, attorney-in-fact for Andrew Hykes
Stock symbol
NARI
Transactions as of
Feb 18, 2023
Transactions value $
$1,524,050
Form type
4
Date filed
2/22/2023, 03:54 PM
Previous filing
Jan 24, 2023
Next filing
Mar 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Award $0 +46.5K +50.03% $0.00 140K Feb 18, 2023 Direct F1
transaction NARI Common Stock Sale -$497K -9K -6.45% $55.19 131K Feb 21, 2023 Direct F2, F3
holding NARI Common Stock 1.55K Feb 18, 2023 By Child 1
holding NARI Common Stock 1.55K Feb 18, 2023 By Child 2
holding NARI Common Stock 1.55K Feb 18, 2023 By Child 3
holding NARI Common Stock 1K Feb 18, 2023 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Stock Options (Right to Buy) Award $2.02M +36.1K $56.00 36.1K Feb 18, 2023 Common Stock 36.1K $56.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 2023 Annual Restricted Stock Units grant ("RSUs"). Vesting Commencement Date begins January 1, 2023, 1/16th of the RSUs shall vest on each quarterly anniversary of the vesting Commencement Date.
F2 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022.
F3 This transaction was executed in multiple trades at prices ranging from $55.00 to $55.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 These options were granted on February 18, 2023 under the Inari Medical, Inc. 2020 Incentive Award Plan and are scheduled to become vested and exercisable on a quarterly basis commencing April 1, 2023.